Oslo, Norway ,December 20, 2021 - Datum AS, a company 100 % owned by Jan Haudemann-Andersen, board member and primary insider atNykode Therapeutics AS , has onDecember 20, 2021 purchased 332,000 shares inNykode Therapeutics AS ("the Company") at an average share price ofNOK 77.70 per share. Following the above transaction, Jan Haudemann Andersen and theDatum Group holds 40,689,050 shares (including 12,060,250 shares through Datum AS) in the Company. Please see further details in the attached document.
Click here for more information
© Oslo Bors ASA, source